| Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor T Walzer, L Chiossone, J Chaix, A Calver, C Carozzo, L Garrigue-Antar, ... Nature immunology 8 (12), 1337-1344, 2007 | 486 | 2007 |
| Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells L Garrigue-Antar, T Muñoz-Antonia, SJ Antonia, J Gesmonde, VF Vellucci, ... Cancer research 55 (18), 3982-3987, 1995 | 307 | 1995 |
| Transforming growth factor β type I receptor kinase mutant associated with metastatic breast cancer T Chen, D Carter, L Garrigue-Antar, M Reiss Cancer research 58 (21), 4805-4810, 1998 | 234 | 1998 |
| Bone morphogenetic protein-1 (BMP-1): identification of the minimal domain structure for procollagen C-proteinase activity N Hartigan, L Garrigue-Antar, KE Kadler Journal of Biological Chemistry 278 (20), 18045-18049, 2003 | 105 | 2003 |
| The soluble α chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer C Badoual, G Bouchaud, NEH Agueznay, E Mortier, S Hans, A Gey, ... Cancer research 68 (10), 3907-3914, 2008 | 97 | 2008 |
| The Role of Transforming Growth Factor β1 in the Fibroblastic Reaction Associated with Rat Colorectal Tumor Development B Lieubeau, L Garrigue, I Barbieux, K Meflah, M Gregoire Cancer research 54 (24), 6526-6532, 1994 | 91 | 1994 |
| Tumor targeting of the IL‐15 superagonist RLI by an anti‐GD2 antibody strongly enhances its antitumor potency M Vincent, A Bessard, D Cochonneau, G Teppaz, V Solé, M Maillasson, ... International journal of cancer 133 (3), 757-765, 2013 | 89 | 2013 |
| Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer. L Garrigue-Antar, RF Souza, VF Vellucci, SJ Meltzer, M Reiss Laboratory Investigation; a Journal of Technical Methods and Pathology 75 (2 …, 1996 | 75 | 1996 |
| Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. RR de Jonge, L Garrigue-Antar, VF Vellucci, M Reiss Oncology research 9 (2), 89-98, 1997 | 74 | 1997 |
| The exon-3-encoded domain of IL-15Rα contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Rα G Bouchaud, L Garrigue-Antar, V Solé, A Quéméner, Y Boublik, E Mortier, ... Journal of molecular biology 382 (1), 1-12, 2008 | 70 | 2008 |
| Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma F Lamoureux, G Picarda, L Garrigue-Antar, M Baud'huin, V Trichet, ... Cancer research 69 (2), 526-536, 2009 | 60 | 2009 |
| Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein L Garrigue-Antar, N Hartigan, KE Kadler Journal of Biological Chemistry 277 (45), 43327-43334, 2002 | 60 | 2002 |
| New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease S Lehri-Boufala, MO Ouidja, V Barbier-Chassefière, E Hénault, ... PloS one 10 (1), e0116641, 2015 | 48 | 2015 |
| Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity L Garrigue-Antar, C Barker, KE Kadler Journal of Biological Chemistry 276 (28), 26237-26242, 2001 | 47 | 2001 |
| Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase … V Petropoulou, L Garrigue-Antar, KE Kadler Journal of Biological Chemistry 280 (24), 22616-22623, 2005 | 44 | 2005 |
| Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse M Vincent, G Teppaz, L Lajoie, V Solé, A Bessard, M Maillasson, S Loisel, ... MAbs 6 (4), 1026-1037, 2014 | 41 | 2014 |
| Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas … RF Souza, L Garrigue-Antar, J Lei, J Yin, R Appel, VF Vellucci, TT Zou, ... Human Cell 9 (3), 229-236, 1996 | 37 | 1996 |
| Deletion of epidermal growth factor-like domains converts mammalian tolloid into a chordinase and effective procollagen C-proteinase L Garrigue-Antar, V François, KE Kadler Journal of Biological Chemistry 279 (48), 49835-49841, 2004 | 36 | 2004 |
| Definition and characterization of an inhibitor for interleukin-31 E Venereau, C Diveu, L Grimaud, E Ravon, J Froger, L Preisser, ... Journal of biological chemistry 285 (20), 14955-14963, 2010 | 32 | 2010 |
| Modulation of inflammation by Cicaderma ointment accelerates skin wound healing C Morin, A Roumegous, G Carpentier, V Barbier-Chassefiere, ... Journal of Pharmacology and Experimental Therapeutics 343 (1), 115-124, 2012 | 28 | 2012 |
